Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Synthesis
International emeritus members?
February 6, 2017
| A version of this story appeared in
Volume 95, Issue 6
As recognized by ACS at times, membership in the society goes beyond U.S. members to many countries worldwide. Therefore, it is somewhat a surprise to see that the group of emeritus members highlighted in the article “Members for life” was parochial (C&EN, Oct. 17, 2016, page 39). How many of the 15,023 emeriti are foreign ACS members—for example, Canadians? And, on that note, this number is predicted to increase.
Victor Snieckus
Kingston, Ontario
Corrections:
Jan. 23, page 26: In the feature story about how thin films helped detect gravitational waves, LMA was referred to as a French specialty coatings firm. It is a specialty coatings research center based at Claud Bernard University Lyon 1 in France.
Jan. 23, page 28: The multipart cover story package on machine learning contained the following errors: The introduction incorrectly stated that GlaxoSmithKline is partnering with a pair of government labs. The firm is partnering with more than two government labs. In the piece on deep learning, Mark Murcko is listed as chief scientific officer of Relay Pharmaceuticals. He is CSO of Relay Therapeutics. In the piece on machine learning, the reaction scheme is credited to Chematica. It should be credited to ChemPlanner.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter